A new study led by UCLA investigators found that combining zanzalintinib, a targeted therapy drug, and atezolizumab, an ...

Results from a trial led by researchers from The University of Texas MD Anderson Cancer Center showed that a targeted therapy ...

212Pb-DOTAMTATE showed significant antitumor activity in PRRT-exposed GEP-NETs, with a 34.6% objective response rate and 96.2% disease control rate. The 18-month progression-free survival and overall ...

Some women with breast cancer don’t respond to chemotherapy, leaving patients and families puzzled. Oncologist Dr. Mandeep ...

Scientists have found a new way to stop cancer growth without damaging healthy cells. Researchers from the Francis Crick Institute and Vividion Therapeutics discovered a compound that blocks the ...

Breast cancer is the most common cancer among women worldwide (WHO, 2023). The Dr. Margarete Fischer-Bosch Institute of ...

Drug candidates spanning oncology, neurology, rare diseases and more are approaching critical development as the calendar turns to 2026.

Startup Leo Cancer Care is transforming proton radiation treatment with a simple idea: having patients sit up instead of ...

For children and young adults diagnosed with osteosarcoma, a common type of bone cancer for that age group, the odds of survival can be devastatingly low (20-30%) when the disease spreads to the lungs ...

The field of cancer immunotherapy has gained significant attention as a promising therapeutic approach, especially in light ...

By Milliam MurigiFor years, the approach to treating illnesses in Kenya has been straightforward: Panadol for headaches, ...